Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo

Chronic lymphocytic leukemia (CLL) is the most frequent B cell malignancy in Caucasian adults. The therapeutic armamentarium against this incurable disease has recently seen a tremendous expansion with the introduction of specific pathway inhibitors and innovative immunotherapy. However, none of the...

Full description

Bibliographic Details

Main Authors:	Schneidt, Viktor (Author) , Dreger, Peter (Author) , Zyl, Dwain George van (Author) , Delecluse, Susanne (Author) , Delecluse, Henri-Jacques (Author)
Format:	Article (Journal)
Language:	English
Published:	2019
In:	Leukemia Year: 2019, Volume: 33, Pages: 88-98
ISSN:	1476-5551
DOI:	10.1038/s41375-018-0160-7
Online Access:	Verlag, Volltext: http://dx.doi.org/10.1038/s41375-018-0160-7 Verlag, Volltext: https://www.nature.com/articles/s41375-018-0160-7
Author Notes:	Viktor Schneidt, Marta Ilecka, Peter Dreger, Dwain G. van Zyl, Susanne Fink, Josef Mautner, Henri-Jacques Delecluse